Glucocorticoid Use and Skin Cancers
Author Information
Author(s): Mark Purdue
Primary Institution: Cancer Care Ontario
Hypothesis
Does the use of glucocorticoids affect the risk of skin cancers such as basal cell carcinoma and squamous cell carcinoma?
Conclusion
The study suggests that the effects of atopic conditions may confound the association between glucocorticoids and skin cancer risk.
Supporting Evidence
- Oral steroid use was associated with increased risk of basal cell carcinoma and squamous cell carcinoma.
- Stronger increases in risk were found for steroid use to treat non-atopic conditions.
- Steroid use for atopic conditions was not associated with increased cancer risk.
Takeaway
Using certain steroids might not increase the risk of skin cancer, but using them for non-allergy reasons could be linked to a higher risk.
Methodology
The study reanalyzed data on oral glucocorticoid use and its association with skin cancer risk, calculating crude odds ratios and confidence intervals.
Potential Biases
Potential bias due to confounding effects of atopic conditions.
Limitations
The odds ratios were not adjusted for other confounding factors, and some cases were not properly categorized.
Statistical Information
Confidence Interval
95% CI
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website